CCEGF logo

Carclo plc (CCEGF) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

CCEGF representa a Carclo plc, una empresa del sector Consumer Cyclical con un precio de $ (capitalización de mercado 0). Calificado con 46/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 46/100

Carclo plc (CCEGF) Descripción General del Negocio al Consumidor

CEOFranciscus Lodewijk Paulus Doorenbosch
Empleados1059
Sede CentralMitcham, GB
Año de la oferta pública inicial (OPI)2012
IndustriaAuto - Parts

Carclo plc, established in 1924, manufactures fine tolerance injection molded plastic components across medical, aerospace, and electronics sectors. With a global presence spanning the UK, North America, and Asia, Carclo leverages its technical plastics and aerospace divisions to serve diverse industrial needs, maintaining a modest profit margin within the consumer cyclical industry.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

Carclo plc presents a mixed investment thesis. The company's specialization in fine tolerance injection molded plastic parts for critical industries like medical and aerospace provides a degree of resilience. The Aerospace division, in particular, offers potential for stable, long-term contracts. However, the company's relatively small market capitalization ($0.05B) and modest profit margin (1.6%) suggest vulnerability to economic downturns and competitive pressures. A P/E ratio of 19.09 indicates that the stock is trading at a premium compared to its earnings. Key value drivers include the ability to secure and maintain contracts in the aerospace sector and the successful development of new applications for its technical plastics. Investors should closely monitor the company's ability to improve profitability and manage its cost structure. The absence of a dividend may deter some investors seeking regular income.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $0.05B reflects its small-cap status within the consumer cyclical sector.
  • P/E ratio of 19.09 suggests the stock is trading at a premium relative to its earnings.
  • Profit margin of 1.6% indicates relatively low profitability, requiring close monitoring of cost management.
  • Gross margin of 56.8% demonstrates strong pricing power in its niche markets.
  • Beta of 0.70 suggests lower volatility compared to the overall market.

Competidores y Pares

Fortalezas

  • Specialized expertise in fine tolerance injection molding.
  • Strong presence in the aerospace industry.
  • Global manufacturing footprint.
  • Long-standing customer relationships.

Debilidades

  • Small market capitalization.
  • Low profit margin.
  • Dependence on cyclical industries.
  • Limited brand recognition.

Catalizadores

  • Ongoing: Increased demand for medical devices requiring high-precision plastic components.
  • Ongoing: Resurgence in the aerospace industry driving demand for specialist components.
  • Upcoming: Potential strategic acquisitions to expand product portfolio and geographic reach.
  • Ongoing: Investment in research and development to create new materials and technologies.
  • Ongoing: Geographic expansion in Asia to tap into high-growth markets.

Riesgos

  • Potential: Economic downturns impacting demand in cyclical industries.
  • Ongoing: Increased competition from other manufacturers of plastic components.
  • Potential: Fluctuations in raw material prices affecting profit margins.
  • Potential: Technological obsolescence requiring continuous innovation.
  • Ongoing: Limited liquidity and higher volatility due to OTC market listing.

Oportunidades de crecimiento

  • Expansion in the medical device market: The increasing demand for sophisticated medical devices presents a significant growth opportunity for Carclo's Technical Plastics division. As medical technology advances, the need for high-precision plastic components will continue to rise. Carclo can leverage its expertise in fine tolerance injection molding to capture a larger share of this market. The global medical device market is projected to reach $600 billion by 2028, providing a substantial runway for growth. Timeline: Ongoing.
  • Increased demand in the aerospace sector: The aerospace industry is experiencing a resurgence, driven by increased air travel and defense spending. Carclo's Aerospace division is well-positioned to benefit from this trend. The company's ability to provide specialist components for both commercial and military aircraft creates a stable and growing revenue stream. The global aerospace market is expected to grow at a rate of 4-5% annually over the next decade. Timeline: Ongoing.
  • Geographic expansion in Asia: The Asian market, particularly China and India, offers significant growth potential for Carclo. These regions are experiencing rapid economic growth and increasing demand for high-quality plastic components and aerospace parts. Carclo can expand its presence in Asia through strategic partnerships and investments in local manufacturing facilities. This expansion can diversify its revenue base and reduce its reliance on mature markets. Timeline: 2-3 years.
  • Development of new materials and technologies: Investing in research and development to create new materials and technologies can provide Carclo with a competitive edge. This includes exploring advanced polymers and molding techniques that can improve the performance and durability of its products. By staying at the forefront of technological innovation, Carclo can attract new customers and expand its market share. Timeline: Ongoing.
  • Strategic acquisitions: Carclo can pursue strategic acquisitions to expand its product portfolio and geographic reach. This includes acquiring companies with complementary technologies or access to new markets. Acquisitions can accelerate Carclo's growth and enhance its competitive position. Careful due diligence and integration are essential for successful acquisitions. Timeline: 3-5 years.

Oportunidades

  • Expansion in the medical device market.
  • Growth in emerging markets.
  • Development of new materials and technologies.
  • Strategic acquisitions.

Amenazas

  • Economic downturns.
  • Increased competition.
  • Fluctuations in raw material prices.
  • Technological obsolescence.

Ventajas competitivas

  • Specialized expertise in fine tolerance injection molding.
  • Long-standing relationships with key customers in the medical and aerospace industries.
  • Global presence with manufacturing facilities in multiple countries.
  • Proprietary technologies and processes for producing high-precision components.

Acerca de CCEGF

Carclo plc, founded in 1924 and based in Ossett, United Kingdom, specializes in the manufacture and sale of fine tolerance injection molded plastic parts. The company operates through three primary segments: Technical Plastics, Aerospace, and Central. The Technical Plastics division focuses on producing high-precision plastic components for the medical, optical, diagnostics, and electronics industries. These components are critical in devices requiring exacting specifications and reliability. The Aerospace division provides specialist components, including control cables, machined components, aerofoil blading, streamline wires, and tie rods, catering to both commercial and military aerospace applications. The Central segment supports the operational and strategic needs of the other two divisions. Carclo's global footprint extends across the United Kingdom, North America, the Czech Republic, China, and India, enabling it to serve a diverse international clientele. The company's products are essential in various applications, ranging from medical devices and diagnostic equipment to aircraft and electronic products. Carclo's commitment to precision and quality has established it as a key supplier in its niche markets. The company's long history and specialized expertise provide a competitive edge in the fine tolerance plastics and aerospace components industries.

Qué hacen

  • Manufactures fine tolerance injection molded plastic parts.
  • Supplies components for the medical, optical, diagnostics, and electronics industries.
  • Provides specialist components for the commercial and military aerospace industries.
  • Offers control cables, machined components, aerofoil blading, streamline wires, and tie rods.
  • Operates in the United Kingdom, North America, the Czech Republic, China, and India.
  • Focuses on high-precision plastic components and aerospace parts.

Modelo de Negocio

  • Manufacturing and selling fine tolerance injection molded plastic parts.
  • Providing specialist components to the aerospace industry.
  • Generating revenue through long-term contracts and project-based sales.
  • Operating through three segments: Technical Plastics, Aerospace, and Central.

Contexto de la Industria

Carclo plc operates within the auto parts industry, a segment of the broader consumer cyclical sector. This industry is influenced by trends in automotive manufacturing, aerospace, and medical device production. The competitive landscape includes companies specializing in precision components and plastic molding. Carclo differentiates itself through its focus on fine tolerance injection molding and its presence in both the technical plastics and aerospace markets. The industry is subject to fluctuations in demand based on economic cycles and technological advancements. Carclo's ability to adapt to changing market conditions and maintain its technological edge is crucial for its long-term success.

Clientes Clave

  • Medical device manufacturers.
  • Aerospace companies (both commercial and military).
  • Electronics manufacturers.
  • Optical and diagnostics equipment producers.
Confianza de la IA: 71% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Carclo plc (CCEGF): Price data unavailable

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CCEGF.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para CCEGF.

MoonshotScore

46/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de CCEGF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Franciscus Lodewijk Paulus Doorenbosch

CEO

Franciscus Lodewijk Paulus Doorenbosch serves as the CEO of Carclo plc. His professional background includes extensive experience in manufacturing and engineering. He has held various leadership positions in multinational corporations, focusing on operational efficiency, strategic planning, and business development. His expertise spans across multiple industries, including automotive, aerospace, and electronics. He is known for his ability to drive growth and improve profitability through innovation and strategic partnerships. His leadership style emphasizes collaboration and a customer-centric approach.

Historial: Since assuming the role of CEO, Franciscus Lodewijk Paulus Doorenbosch has focused on streamlining operations and improving the company's financial performance. Key initiatives include implementing cost-saving measures, expanding the company's presence in emerging markets, and investing in research and development. Under his leadership, Carclo has secured several significant contracts in the aerospace sector and has launched new products in the medical device market.

Información del mercado OTC de CCEGF

The OTC Other tier represents the lowest tier of the OTC market, indicating that Carclo plc may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited reporting requirements and may not be subject to the same level of regulatory scrutiny as those listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk due to the potential for less transparency and liquidity.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity on the OTC Other market is typically very limited. Trading volume is often low, and bid-ask spreads can be wide, making it difficult to buy or sell shares quickly and at a favorable price. Investors may experience significant price slippage when executing trades. The limited liquidity can also increase price volatility.
Factores de riesgo OTC:
  • Limited liquidity due to low trading volume.
  • Lack of regulatory oversight and transparency.
  • Potential for wider bid-ask spreads.
  • Higher price volatility.
  • Risk of delisting or suspension of trading.
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and disclosures.
  • Assess the company's management team and their track record.
  • Evaluate the company's business model and competitive landscape.
  • Review the company's legal and regulatory filings.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor.
  • Check for any history of regulatory issues or fraud.
Señales de legitimidad:
  • Long operating history (incorporated in 1924).
  • Global presence with operations in multiple countries.
  • Established customer base in the medical and aerospace industries.
  • Specialized expertise in fine tolerance injection molding.
  • Employment of over 1000 people.

Preguntas Comunes Sobre CCEGF

¿Cuáles son los factores clave para evaluar CCEGF?

Carclo plc (CCEGF) actualmente tiene una puntuación IA de 46/100, indicando puntuación baja. Fortaleza clave: Specialized expertise in fine tolerance injection molding.. Riesgo principal a monitorear: Potential: Economic downturns impacting demand in cyclical industries.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de CCEGF?

CCEGF actualmente puntúa 46/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de CCEGF?

Los precios de CCEGF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre CCEGF?

La cobertura de analistas para CCEGF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en CCEGF?

Las categorías de riesgo para CCEGF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Economic downturns impacting demand in cyclical industries.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de CCEGF?

La relación P/E para CCEGF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está CCEGF sobrevalorada o infravalorada?

Determinar si Carclo plc (CCEGF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de CCEGF?

Carclo plc (CCEGF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • OTC market data may be less reliable than major exchange data.
  • Analyst coverage may be limited due to the company's size and listing.
Fuentes de datos

Popular Stocks